CYP2A6 and urinary bladder cancer: A small-scale case-control study has revealed the association of CYP2A6*1/*4 or *4/ *4 genotypes with decreased susceptibility to bladder cancer [48]; however, the relationship between CYP2A6 SNPs and bladder cancer risk has not been demonstrated by GWASs [13–17].